We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$82.5B
AUM Growth
+$5.26B
(+6.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
38.94%
Holding
962
New
129
Increased
342
Reduced
292
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$429M |
| 2 |
Airbnb
ABNB
|
+$235M |
| 3 |
T-Mobile US
TMUS
|
+$156M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
+$139M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$488M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$222M |
| 3 |
Expeditors International
EXPD
|
+$191M |
| 4 |
Qualcomm
QCOM
|
+$187M |
| 5 |
CERN
Cerner Corp
CERN
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.12% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Communication Services | 13.72% |
| 4 | Healthcare | 12.84% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
McGrath RentCorp
MGRC
$2.92B
| $66.9M | 0.08% |
819,551
+28,990
| +4% | +$2.39M |
|
102
Shutterstock
SSTK
$219M
| $66.1M | 0.08% |
673,225
+74,310
| +12% | +$6.81M |
|
103
Albany International
AIN
$1.78B
| $66.1M | 0.08% |
740,074
+111,404
| +18% | +$9.75M |
|
|
PRMW
104
DELISTED
Primo Water Corporation
PRMW
| $64.6M | 0.08% |
3,860,649
-282,376
| -7% | -$4.77M |
|
105
Casella Waste Systems
CWST
$5.69B
| $64.2M | 0.08% |
1,012,003
-20,570
| -2% | -$1.37M |
|
106
NXP Semiconductors
NXPI
$60.4B
| $63.6M | 0.08% |
308,926
+15,447
| +5% | +$3.1M |
|
107
National Vision
EYE
$1.81B
| $62.9M | 0.08% |
1,229,995
-24,911
| -2% | -$1.22M |
|
108
Ameris Bancorp
ABCB
$5.89B
| $62.5M | 0.08% |
1,233,896
+69,526
| +6% | +$3.73M |
|
109
Brunswick
BC
$5.28B
| $62M | 0.08% |
622,574
+16,137
| +3% | +$1.64M |
|
110
Wingstop
WING
$3.18B
| $61.8M | 0.08% |
392,319
-7,977
| -2% | -$1.15M |
|
111
WillScot Mobile Mini Holdings
WSC
$4.41B
| $61.5M | 0.07% |
2,208,419
-43,972
| -2% | -$1.26M |
|
112
Baidu
BIDU
$37.2B
| $61.4M | 0.07% |
301,235
+8,159
| +3% | +$1.63M |
|
113
Itron
ITRI
$4.54B
| $61.3M | 0.07% |
613,168
-12,351
| -2% | -$1.15M |
|
114
Ingersoll Rand
IR
$33.7B
| $60.8M | 0.07% |
1,245,837
+49,135
| +4% | +$2.41M |
|
115
LCI Industries
LCII
$2.65B
| $60.4M | 0.07% |
459,268
+34,518
| +8% | +$4.85M |
|
116
Concentrix
CNXC
$1.57B
| $59.8M | 0.07% |
372,007
+8,025
| +2% | +$1.23M |
|
|
DRNA
117
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $58.2M | 0.07% |
1,560,057
-31,511
| -2% | -$966K |
|
118
Ambev
ABEV
$46.4B
| $58.1M | 0.07% |
16,899,431
+102,734
| +0.6% | +$334K |
|
119
TechTarget
TTGT
$278M
| $58M | 0.07% |
748,701
+161,512
| +28% | +$11.6M |
|
120
STAAR Surgical
STAA
$1.21B
| $56.1M | 0.07% |
368,163
-157,995
| -30% | -$20.8M |
|
121
MaxLinear
MXL
$6.8B
| $55.2M | 0.07% |
1,299,750
+114,404
| +10% | +$4.27M |
|
|
NUVA
122
DELISTED
NuVasive, Inc.
NUVA
| $54.7M | 0.07% |
806,998
-16,390
| -2% | -$1.12M |
|
123
Dorman Products
DORM
$4.18B
| $53.9M | 0.07% |
520,052
-10,284
| -2% | -$1.05M |
|
124
Boot Barn
BOOT
$4.95B
| $53.5M | 0.06% |
636,027
+75,896
| +14% | +$5.56M |
|
125
Herc Holdings
HRI
$5.61B
| $53.4M | 0.06% |
476,683
+61,811
| +15% | +$6.54M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2021 Portfolio in Review
As of Q2 2021, Loomis, Sayles & Company held 962 positions worth $82.5B, up 6.8% from $77.2B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Loomis, Sayles & Company's Q2 2021 filing shows 129 new, 342 increased, 292 reduced and 136 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 946,065 shares worth $160M. The largest sale was Deere & Co, an estimated $488M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q2 2021 buy was Alnylam Pharmaceuticals: 946,065 shares worth $160M.
- Loomis, Sayles & Company added most to Vertex Pharmaceuticals in Q2 2021, an estimated $429M increase.
- Loomis, Sayles & Company's biggest Q2 2021 reduction was Deere & Co, cutting an estimated $488M.
- Loomis, Sayles & Company fully exited Goosehead Insurance in Q2 2021, selling an estimated $66.6M.
- Loomis, Sayles & Company's ten largest holdings make up 39% of its $82.5B portfolio in Q2 2021.
- Loomis, Sayles & Company opened 129 new positions and closed 136 in Q2 2021.
- Loomis, Sayles & Company's portfolio value rose 6.8% quarter-over-quarter to $82.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2021, filed 13 Aug 2021.